(Q39934743)

English

Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation

scientific article published on November 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

based on heuristic

inferred from title

author name string

Jianshan Mao

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Zefeng Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Yongming Fang

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Haijun Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Jinghong Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Jinjia Ye

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Shu Zheng

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Yongliang Zhu

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

2120-2127

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Molecular-pathological prognostic factors of gastric cancer: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Partial purification and characterization of human hepatoma-derived growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Fetal lung development: airway pressure enhances the expression of developmental genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

An endothelial growth factor involved in rat renal development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Expression of hepatoma-derived growth factor in hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Expression of hepatoma‐derived growth factor in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

PI 3-kinase, Akt and cell survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Overexpressed beta-catenin blocks nitric oxide-induced apoptosis in colonic cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00928.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2008.00928.X

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39934743&oldid=1879063382"